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Introduction: In our institution, patients with suspected pulmonary TB undergo multiple
induced-sputum sampling for microscopy, culture and nucleic acid amplification (NAA) with
the MTD Gen-probe assay. Those with negative induced-sputum results still suspected with
TB are then referred for bronchoscopy. We sought to determine the diagnostic yield of bron-
choscopy in these patients with negative initial induced-sputum results both via smear and NAA
testing.
Methods: We identified 30 consecutive cases of suspected pulmonary TB between 2001 and
2007, who had undergone a diagnostic bronchoscopy after negative results on induced-sputum
smears and the MTD Gen-probe on at least 2 samples.
Results: The cohort (M Z 20 & F Z 10) had a median age of 37 (range 16e85 yrs); were
predominantly foreign born (27/30); HIV-negative (29/30) individuals with strongly positive
TST’s (mean 18 þ 5 mm). Induced-sputum cultures were negative for M-TB in all patients after
a full 60-day incubation period. BAL was culture positive for M-TB in 3/30 cases (10%) with 2
strains being pan-sensitive and the third being INH resistant. BAL microscopy with acid-fast
smear (nZ 30) and BAL Gen-probe (nZ 23) were negative in all cases. A third of the patients
(9/27, 33%) with negative bronchoscopy results were treated for culture negative TB. Treat-
ment for latent TB was initiated in 5/27 (18%) individuals whereas 13/27 (48%) received no
further treatment.7 284 2964; fax: þ1 507 266 4372.
du (V.N. Iyer).
1 Elsevier Ltd. All rights reserved.
Bronchoscopy in suspected pulmonary TB 1085Conclusion: Bronchoscopy provided diagnostic confirmation of pulmonary TB in 10% of subjects
at least 2 negative induced-sputum samples by smear microscopy and NAA testing.
ª 2011 Elsevier Ltd. All rights reserved.Introduction
Tuberculosis is a worldwide public health crisis of
immense proportions and the majority of the world’s TB
burden is carried by developing countries with limited
resources. The diagnosis of pulmonary TB can be obtained
from microscopy and culture of a number of different
sources including regular sputum, induced sputum, gastric
washings and bronchoscopy. The sensitivity, specificity
and diagnostic yield of each of these tests vary widely
between studies.1e7 Sputum microscopy and culture are
relatively easy to perform but can be negative in
a substantial proportion of pulmonary TB patients with
reported sensitivities ranging from 25 to 45%.1,8,9 Sputum
induction with hypertonic saline requires additional
resource allocation and manpower training, but has been
shown to increase the diagnostic yield of sputum exami-
nation in several studies.10e12 Several studies have
confirmed the higher diagnostic yield of bronchoscopy
over sputum examination in the diagnosis of pulmonary TB
both from higher microscopy and higher culture positivity
results.13e15 Clinicians often face a real dilemma when
a patient suspected with active pulmonary TB has multiple
negative induced-sputum results. They have a choice to
either proceed with empiric treatment for pulmonary TB
or to perform an invasive test like bronchoscopy in order
to confirm the diagnosis. The question then is whether
bronchoscopy offers any additional diagnostic yield in
patients suspected with active pulmonary TB and with
multiple negative induced-sputum results. The existing
literature on this subject reports varying diagnostic yields
for bronchoscopy depending on the study design and
patient population studied. In addition, none of these
studies have included patients who had undergone NAA
testing on sputum samples prior to bronchoscopy. Higher
diagnostic yields are obtained from patients undergoing
bronchoscopy because of an inability to expectorate any
sputum. This is in contrast to patients who underwent
bronchoscopy after an adequate sputum sample was
determined to be smear negative.13,16,17 Other studies
however have shown no additional yield of bronchoscopy
over sputum induction.18,19 We performed this study to
answer the clinical question as to whether bronchoscopy
provides additional diagnostic yield after multiple nega-
tive induced-sputum smear and NAA testing.Methods
This was a retrospective study that was approved by the
institutional review board at the Mayo Clinic, Rochester,
Minnesota, USA. Only patients who had consented to have
their medical charts available for research studies were
included in this study. The data were analyzed using JMP
7.0 (SAS Institute, Cary, North Carolina).Patient population
In our center, patients suspected of pulmonary TB were
first evaluated with repeated induced-sputum collections
(see below for technique) for acid-fast smear usually on at
least three consecutive days. Nucleic acid amplification
(NAA) testing specific for M-TB is performed using the
MTD Gen-probe test on at least 2 of these samples.
Bronchoscopy is often considered while awaiting sputum
culture results if a clinical suspicion for TB persists even
after 2 or more induced-sputum samples were negative by
smear and the MTD Gen-probe test. We identified sus-
pected pulmonary TB patients from 2001 to 2008 who
underwent a bronchoscopy after at least 2 negative
induced-sputum smear and NAA tests. The charts of these
consecutive patients were abstracted for relevant data
including demographics, co-morbidities and bronchos-
copy/sputum results. Data about PPD skin testing and the
QuantiFERON-TB Gold test were also obtained from the
charts when available.
PPD skin test
The PPD skin test was performed using either Tubersol or
Aprisol at a dose of 5 TU injected intradermally into the
forearm. The reaction was read after a period of 48 h
measuring induration.
Amplified mycobacterium tuberculosis MTD Gen-probe
test
This test was performed according to the manufacturer’s
recommendations. The test was performed both on sputum
samples and on BAL specimens.20,21
QuantiFERON-TB Gold test
The QuantiFERON-TB Gold test is an interferon-gamma
release assay that detects T-cell immune responses to
antigens specific to M-TB. The details about this test and its
methodology are detailed elsewhere.22
Induced-sputum technique
Each induced-sputum collection was performed using 10%
hypertonic saline nebulized through a mouthpiece using
a DeVilbiss ultrasonic nebulizer for at least 20 min. Morning
samples were obtained on consecutive days whenever
possible. Each sample was then centrifuged and concen-
trated according to standard published methods and sub-
jected to acid fast smear examination, culture and MTD
Gen-probe testing. The MTD Gen-probe test was per-
formed on at least 2 of the induced-sputum samples as per
established protocols described in detail elsewhere.20,21 All
sputum testing was performed either at the Mayo Clinic or
at the Olmsted County TB Clinic. Both facilities have CLIA
certified labs with standardized and rigorous procedures for
sputum induction.
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Bronchoscopies were performed by fellows in pulmonary-
critical care medicine under the supervision of experienced
faculty members at the Mayo Clinic. Bronchoalveolar lavage
specimens were obtained by wedging the bronchoscope
into the radiologically involved lung segment and instilling
20 cc aliquots of saline solution followed by a 5 ml air
chaser. Repeat aliquots were instilled and aspirated until
a total of 35e40 cc of fluid return was obtained. Trans-
bronchial biopsies were obtained under fluoroscopic guid-
ance from the involved lung segment whenever possible.
The use of lidocaine was minimized as much as possible
because of its known antimicrobial properties.230
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Figure 1 Symptoms.Results
The study cohort identified 20males and 10 females (Table 1)
with a median age of 37 (range 16e85 yrs). Cough was the
most common symptom (nZ 18, 60%) followed byweight loss
(nZ 7, 23%), fever (nZ 6, 20%), hemoptysis (nZ 4, 13%) and
chest pain (n Z 4, 13%). Cases were predominantly foreign
born (27/30); HIV negative (29/30) individuals with strongly
positive TST’s (mean 18 mm). QuantiFERON-TB Gold serum
testing was performed in 14 patients and was positive in 13 of
thesepatients. Previous treatment forM-TBwas recorded in 8
patients (4 for LTBI and 4 for active TB). Chest X-ray and CT
results predominantly showed unilateral upper lobe disease
(20/30) (Fig. 1).Table 1 Demographic data (n Z 30).
Variables Distribution
Age (median, IQR) 37 years (IQR, 22e63 years)
Range: 16e85 years
Sex
Male n Z 20 (67%)
Female n Z 10 (33%)
Previous TB
treatment
Active TB n Z 4 (13%)
Latent TB n Z 4 (13%)
None n Z 22 (69%)
BCG status
Vaccinated n Z 3 (10%)
Unvaccinated n Z 2 (7%)
Unknown n Z 25 (83%)
Tuberculin skin
test (mm)
Positive n Z 23 (mean 18 mm)
Unknown n Z 7 (positive by history
in 4 of these individuals)
QuantiFERON-TB Gold
Positive n Z 13 (43%)
Negative n Z 1 (3%)
Not done n Z 16 (53%)Prior to bronchoscopy, the numbers of induced-sputum
samples collected on each patient were as follows: 2
samples in 6/30 patients (20%), 3 collections in 22/30
patients (73%) and 6 collections in 2 patients (7%). The
MTD Gen-probe NAA test was performed in all patients on
at least 2 induced-sputum samples and these were all
negative (69 tests, 30 patients). Induced-sputum cultures
were negative for M-TB culture after a full 60-day incuba-
tion period in all patients (92 samples, 30 patients), con-
firming sputum negativity.
Bronchoscopy was performed in all patients within a few
days after negative induced-sputum smear and NAA test
results. (Table 2) BAL collections were culture positive for
M-TB in 3/30 cases (10%). BAL microscopy (nZ 30) and BAL
Gen-probe NAA tests (n Z 23) were negative in all cases.
Transbronchial biopsies were obtained in 14 patients with
one biopsy each showing fibrosis and organizing pneumonia.
(Table 3) Normal biopsies were obtained in 10/14 cases.
Non-caseating granulomas were obtained in 2/14 patients
with concurrent positive BAL culture results in one of these
two patients. All biopsies simultaneously underwent AFB
culture with no positive results.
Gastric washings with culture and NAA testing were
performed in two patients (2 samples each) and were
negative in both cases.
Pan-sensitive organisms were isolated from BAL fluid in
2/3 cases and Isoniazid resistance was detected in the third
case. All three individuals received treatment for culture
positive TB (Table 4). The QuantiFERON-TB Gold test was
positive in two of these patients and was not done in the
3rd patient. Treatment for culture negative TB was started
in a third of the patients (9/27, 33%) with negativeTable 2 Results of bronchoscopy (n Z 30).
Bronchoscopy results
for M-Tb
Smear
(n Z 30)
Gen-probe
(n Z 23)
Culture
(n Z 30)
Positive 0 0 3
Negative 30 23 27
Table 3 Transbronchial biopsy results (n Z 14).
Transbronchial biopsy pathology MTD Gen-probe on BAL BAL culture
Non-caseating granuloma (n Z 2) Negative (2/2) Positive (1/2)
Fibrosis (n Z 1) Negative (1/1) Negative (1/1)
Organizing pneumonia (n Z 1) Negative (1/1) Negative (1/1)
Normal (n Z 10) Negative (10/10) Positive (2/10)
Bronchoscopy in suspected pulmonary TB 1087bronchoscopy results. After completion of this treatment, 4
showed signs of radiological improvement, 3 had stable
radiological disease and 1 patient was lost to follow up.
Treatment for latent TB was initiated in 5/27 (18%) indi-
viduals whereas 13/27 (48%) received no TB treatment and
were treated with antibiotics with improvement in 7/13
and stability in 4/13 individuals.Discussion
The diagnosis of pulmonary TB in patients with negative
expectorated sputum results remains challenging due to
the variable diagnostic yields of any single test.1,16 Sputum
induction, gastric lavage and bronchoscopy have all been
reported to increase diagnostic yield and have useful and
often complimentary roles in the diagnosis of pulmonary
TB.10e14,16,19,24e26
We report the diagnostic yield of bronchoscopy in
patients with suspected pulmonary TB and with negative
results on smear and NAA test results on at least 2 induced-
sputum specimens. All patients in our study underwent
induced-sputum collection on at least 2 occasions and
a majority underwent 3 or more sputum inductions (73%).
Culture of the BAL fluid obtained at bronchoscopy
successfully identified 3 cases (10%, 3/30) of pulmonary TB
that would have been otherwise missed by smear and NAA
testing of multiple induced-sputum samples. In addition all
patients had negative culture results on the induced-
sputum samples after full 60-day incubation, thus con-
firming true sputum negativity.
The role of Bronchoscopy in the diagnosis of pulmonary TB
has been addressed before3,13,14,16e19,26e30 with considerably
different yields reported across studies. These differences in
yield from bronchoscopy reflect differences in study design
and the patient population being studied. In some of these
reports, patients with negative expectorated sputum results,Table 4 Treatment outcomes (n Z 30).
Group Number of p
Culture positive TB (pan-
sensitive)
2
Culture positive TB (INH-
resistance)
1
Latent TB 5
Culture negative TB 9
No treatment 13did not undergo sputum induction as the next step, but pro-
ceeded directly to bronchoscopy. Not surprisingly, these
studies reported a high diagnostic yield for bronchoscopy of
between 32.5%26 and 90%.13 Other studies focussed on
patients who were sputum negative, but also included those
who were unable to expectorate any sputum31 and again
reported relatively high diagnostic yields for bronchoscopy.
Induced-sputum has been widely recognized to increase
diagnostic yields over spontaneously expectorated sputum.
The question of whether bronchoscopy provides any addi-
tional diagnostic yield over induced-sputum has yielded
conflicting reports. Schoch et al. compared the yield
between regular sputum, induced-sputum and bronchos-
copy in the diagnosis of TB in an immigrant population with
suspected pulmonary TB. They found that bronchoscopy
had a significantly higher diagnostic yield when compared
to multiple induced-sputum samples. They also found that
the diagnostic yield of any one modality was low and varied
from 36% to 63%, emphasizing the complimentary nature of
each of these tests.17 Brown et al. on the other hand per-
formed bronchoscopies in 21 patients with negative
induced-sputum results and did not find any additional yield
of performing this procedure.16 McWilliams also reported
similar results with induced-sputum yielding 26/27 culture
positive cases whereas BAL yielded only 14/27.18 Anderson
similarly compared induced-sputum (without NAA testing)
with bronchoscopy in patients with negative sputum results
and reported a better yield from induced-sputum.19
Several explanations have been proposed by these
authors and others to explain the lower yield from bron-
choscopy. They speculated that lower yields from bron-
choscopy may have resulted from the inexperience of the
operators performing the procedure. The use of lidocaine
during bronchoscopy has also been implicated in these
regards. Lidocaine has well described antibacterial and
antifungal properties.32,33 In addition, Lidocaine has been
shown to have specific inhibitory effects on growth ofatients Treatment
2 months with 4 drugs
4 months with 2 drugs
Initially started on 2 months
with 4 drugs, then switched to
6 months with 3 drugs (INH
dropped)
9 months of INH
6 months with 4 drug
No treatment
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bacteria in culture. As little as 1 ml of 2% lidocaine instilled
in the tracheobronchial tree was shown to reduce the
culture positivity rate for M. tuberculosis by 50%.33 Limiting
the amount of lidocaine used during bronchoscopy has its
practical limitations due to patient comfort related issues,
but may be responsible for a substantial decrease in the
yield from this procedure.
Our study differs from previous studies in several
respects. Firstly, every patient underwent sputum induc-
tion on multiple occasions as per the protocol in our insti-
tution. Attempts were made to collect at least 3 induced-
sputum samples on separate days.
Secondly, in each patient, at least 2 of these induced-
sputum samples also underwent concurrent NAA testing
using the MTD Gen-probe test. (Gen.-probe Inc. San Diego,
CA). NAA tests are very sensitive and specific (>90%) in
smear positive cases and at least moderately sensitive
(50e80%) in smear negative cases. The incorporation of
routine NAA testing on multiple induced-sputum samples in
our clinical practice has resulted in a quicker turnaround
time and lower false negative rate for induced-sputum
samples.34 Thus the individuals referred for bronchoscopy
in our practice were more likely to be truly sputum
‘negative’. This is corroborated by the fact that all
induced-sputum samples were culture negative at the end
of the 60-day incubation period.
Thirdly, patients were considered for bronchoscopy only
after multiple induced-sputum samples were negative by
microscopy and NAA testing. This step-wise approach
incorporating universal sputum induction and NAA testing
likely reduced the yield of bronchoscopy in our patients
when compared to other published studies on this
subject.13,26
The decision to proceed with bronchoscopy for the
purposes of confirming TB by smear and/or culture confir-
mation is influenced by several factors. Drug susceptibility
testing can obviously be performed only on culture
confirmed cases of M-TB. The global spread of MDR and
XDR-TB challenge the existing paradigm of empiric standard
multidrug treatment in sputum negative cases of suspected
pulmonary TB. This is especially true of patients coming
from areas known to harbor high rates of drug resistance. In
Olmsted County, Minnesota (where the study was per-
formed), the numbers of new TB cases have been increasing
over the past decade with a majority of the new cases
occurring in foreign-born individuals (78%).35 Similar
statistics have been reported for the state of Minnesota as
a whole.36 The majority of drug resistance has been
reported in foreign born individuals with prevalence rates
around 13% for one or more 1st line agents and around 10%
for isoniazid resistance.35e37 In 2006 a single case of XDR-TB
was also reported in the state. Patients co-infected with
both HIV and TB have higher rates of drug resistant TB and
drug susceptibility testing is very important in these
patients.38,39
Our study reaffirms the diagnostic utility of bronchos-
copy in culture confirmation of TB even after negative
results on multiple induced-sputum samples.40 Bronchos-
copy is also useful in the identification of alternative
diagnoses including other granulomatous lung diseases
and malignancy. One note of caution is that rigorousdecontamination procedures and strict protocols need to
be in place in order to avoid nosocomial transmission of TB
and other infectious agents via contaminated bronchoscopy
equipment.41e43
Although bronchoscopy may be useful in resource rich
and low TB endemicity areas, much of worldwide TB occurs
in developing countries where resources are severely
limited. Given the high pre-test probability for TB, a high
proportion of patients receive treatment for TB after
negative sputum results due to diagnostic resource
constraints.44 Alternate sputum based methods using real
time PCR that can simultaneously diagnose TB and identify
drug resistant strains appear to be a promising new avenue
in settings where the role of bronchoscopy is limited by cost
and logistical constraints.45
In summary, our study shows that bronchoscopy is useful
in obtaining culture confirmation of pulmonary TB in about
10% of patients with negative results on multiple induced-
sputum samples by microscopy and NAA testing. In resource
poor settings, the role of bronchoscopy in TB diagnosis is
likely to be limited due to availability, cost and logistical
challenges.Conflict of interest
The authors report no conflicts of interest.
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